Anti-inflammatory medications for obstructive sleep apnoea in children

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 1, 2020, Pages

  Kuhle, Stefan ^a   Hoffmann, Dorle U ^b   Mitra, Souvik ^c   Urschitz, Michael S ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID DERIVATIVE; MONTELUKAST; PLACEBO; STEROID; ACETIC ACID; QUINOLINE DERIVATIVE; ACETIC ACID DERIVATIVE; ANDROSTANE DERIVATIVE; BUDESONIDE; FLUTICASONE;

APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; CHILD; CLINICAL OUTCOME; DESATURATION INDEX; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; EVIDENCE BASED PRACTICE; FOLLOW UP; HEADACHE; HUMAN; MEDICAL SPECIALIST; NADIR ARTERIAL OXYGEN SATURATION; NASAL DISCOMFORT; NAUSEA; NOSE DISEASE; OUTPATIENT; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY AROUSAL INDEX; RESPIRATORY DISTURBANCE INDEX; RESPIRATORY TRACT PARAMETERS; REVIEW; RISK FACTOR; SCORING SYSTEM; SHORT COURSE THERAPY; SLEEP DISORDERED BREATHING; SURGERY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TERTIARY CARE CENTER; THROAT DISCOMFORT; THROAT DISEASE; TONSIL; TONSILLAR SIZE; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; ADENOIDECTOMY; ADOLESCENT; FEMALE; INFANT; MALE; META ANALYSIS; PRESCHOOL CHILD; TONSILLECTOMY; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SLEEP APNEA SYNDROME;

ACETATES; ADENOIDECTOMY; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP APNEA, OBSTRUCTIVE; TONSILLECTOMY; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANDROSTADIENES; BUDESONIDE;

EID: 79952258191     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007074.pub3     Document Type: Review

References (90)

1. Brouillette RT, Manoukian JJ, Ducharme FM, Oudjane K, Earle LG, Ladan S, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea (OSA) due to adenotonsillar hypertrophy (ATH). American Journal of Respiratory and Critical Care Medicine 2000;161:A701. x-wiley/crsRef/12649894
2. Brouillette RT, Manoukian JJ, Ducharme FM, Oudjhane, K, Earle LG, Ladan S, et al. Efficacy of fluticasone nasal spray for pediatric obstructive apnea. Journal of Pediatrics 2001;138(6):838-44. x-wiley/crsRef/2922532
3. Chan CC, Au CT, Lam HS, Lee DL, Wing YK, Li AM. Intranasal corticosteroids for mild childhood obstructive sleep apnea--a randomized, placebo-controlled study. Sleep Medicine 2015;16(3):358-63. [DOI: 10.1016/j.sleep.2014.10.015]x-wiley/crsRef/12649896
4. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics 2012;130(3):e575-80. [DOI: 10.1542/peds.2012-0310]x-wiley/crsRef/12649898
5. Goldbart AD, Tal A. Leukotriene modifier therapy for sleep disordered breathing in children. A double blind placebo controlled study. American Journal of Respiratory and Critical Care Medicine 2009;Suppl:A6344. x-wiley/crsRef/12649899
6. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008;122(1):e149-55. x-wiley/crsRef/2922536
7. Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for children with obstructive sleep apnea: results of a double-blind, randomized, placebo-controlled trial. Annals of the American Thoracic Society 2016;13(10):1736-41. [DOI: 10.1513/AnnalsATS.201606-432OC]x-wiley/crsRef/12649901
8. Abad VC, Guilleminault C. Pharmacological management of sleep apnea. Expert Opinion on Pharmacotherapy 2006;7(1):11-23. x-wiley/crsRef/2922538
9. Al-Saadi MM. The clinical utility of montelukast in paediatric respiratory diseases. Pakistan Journal of Medical Sciences 2007;23(6):962-9. x-wiley/crsRef/2922540
10. Arens R. Is it time to consider a new treatment for children with sleep-disordered breathing?. American Journal of Respiratory and Critical Care Medicine 2005;172(3):264-5. x-wiley/crsRef/2922542
11. Au CT, Li AM. Obstructive sleep breathing disorders. Pediatric Clinics of North America 2009;56(1):243-59. x-wiley/crsRef/2922544
12. Bianchi S, Callegari M, Cama E, Ciambra R, Causa P, Crupi I, et al. Is there a pharmacologic therapy for sleep apnea syndrome? [Esiste una terapia farmacologica per la sindrome delle apnee notturne?]. Quaderni ACP 2007;14:73-4. x-wiley/crsRef/2922546
13. Chadha NK, Zhang L, Mendoza-Sassi RA, Cesar JA. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work?. Otolaryngology ‒ Head and Neck Surgery 2009;140(2):139-47. x-wiley/crsRef/2922550
14. Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. International Journal of Pediatric Otorhinolaryngology 2015;79(10):1599-1608. x-wiley/crsRef/12649903
15. Ciprandi G, Varricchio A, Capasso M, Varricchio AM, De Lucia A, Ascione E, et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. International Journal of Immunopathology and Pharmacology 2007;20(4):833-6. x-wiley/crsRef/2922552
16. Cohen-Gogo S, Do NT, Levy D, Metreau J, Mornand P, Parisot P, et al. Sleep-disordered breathing in children [Les troubles respiratoires du sommeil chez l'enfant]. Archives de Pediatrie 2009;16(2):123-31. x-wiley/crsRef/2922554
17. Criscuoli G, D'Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N, et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 2003;111(3):236-8. x-wiley/crsRef/2922556
18. Demirhan H, Aksoy F, Ozturan O, Yildirim YS, Veyseller B. Medical treatment of adenoid hypertrophy with “fluticasone propionate nasal drops”. International Journal of Pediatric Otorhinolaryngology 2010;74(7):773-6. x-wiley/crsRef/12649905
19. Economou N, Ferini-Strambi L, Steiropoulos P. Sleep-related drug therapy in special conditions: children. Sleep Medicine Clinics 2018;13(2):251-62. x-wiley/crsRef/12649907
20. Erler T, Paditz E. Obstructive sleep apnea syndrome in children: a state-of-the-art review. Treatments in Respiratory Medicine 2004;3(2):107-22. x-wiley/crsRef/2922558
21. Gelardi M, Iannuzzi L, Greco MA, Cazzaniga S, Naldi L, De LC, et al. Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal in the treatment of sub- obstructive adenotonsillar hypertrophy and related diseases. International Journal of Pediatric Otorhinolaryngology 2013;77(11):1818-24. x-wiley/crsRef/12649909
22. Goldbart AD, Tal A. Inflammation and sleep disordered breathing in children: a state-of-the-art review. Pediatric Pulmonology 2008;43(12):1151-60. x-wiley/crsRef/2922560
23. 2013-004620-10. Study of nasal steroid spray treatment on the quality of life and sleep parameters in children with sleep disorder breathing. clinicaltrialsregister.eu/ctr-search/trial/2013-004620-10/SE (first received 16 October 2014). x-wiley/crsRef/12649911
24. Gudnadottir G, Ellegård E, Hellgren J. Intranasal budesonide and quality of life in pediatric sleep-disordered breathing: a randomized controlled trial. Otolaryngology and Head and Neck Surgery 2018;158(4):752-9. x-wiley/crsRef/12649912
25. Hoban TF, Chervin RD. Pediatric sleep-related breathing disorders and restless legs syndrome: how children are different. Neurologist 2005;11(6):325-37. x-wiley/crsRef/2922562
26. Hoban TF, Chervin RD. Sleep-related breathing disorders of childhood: description and clinical picture, diagnosis, and treatment approaches. Sleep Medicine Clinics 2007;2(3):445-62. x-wiley/crsRef/2922564
27. Hoban TF. Sleep disorders in children. Annals of the New York Academy of Sciences 2010;1184:1-14. x-wiley/crsRef/2922566
28. Kaditis AG, Alexopoulos EI, Syrogiannopoulos GA. Assessing the role of antiinflammatory medications in children with mild sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine 2006;173(3):358-9. x-wiley/crsRef/2922568
29. Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opinion on Investigational Drugs 2013;22(1):71-85. x-wiley/crsRef/12649914
30. Kotagal S. Childhood obstructive sleep apnea. BMJ 2005;330(7498):978-9. x-wiley/crsRef/2922570
31. Kuhle S, Urschitz MS, Eitner S, Poets CF. Interventions for obstructive sleep apnea in children: a systematic review. Sleep Medicine Reviews 2009;13(2):123-31. x-wiley/crsRef/2922572
32. Lam JC, Mason TBA. Treatment of sleep disorders in children. Current Treatment Options in Neurology 2007;9(6):404-13. x-wiley/crsRef/2922574
33. Lepcha A, Kurien M, Job A, Jeyaseelan L, Thomas K. Chronic adenoid hypertrophy in children - is steroid nasal spray beneficial?. Indian Journal of Otolaryngology ‒ Head and Neck Surgery 2002;54(4):280-4. x-wiley/crsRef/2922576
34. Li AM, Chan DFY, Fok TF, Wing YK. Childhood obstructive sleep apnea: an update. Hong Kong Medical Journal 2004;10(6):406-13. x-wiley/crsRef/2922578
35. Lipton AJ, Gozal D. Treatment of obstructive sleep apnea in children: do we really know how?. Sleep Medicine Reviews 2003;7(1):61-80. x-wiley/crsRef/2922580
36. Ng DK, Cheung JM. Childhood snoring - what's the problem?. Hong Kong Practitioner 2000;22(10):495-503. x-wiley/crsRef/2922582
37. Nixon GM, Brouillette RT. Obstructive sleep apnea in children: do intranasal corticosteroids help?. American Journal of Respiratory Medicine 2002;1(3):159-66. x-wiley/crsRef/2922584
38. Nixon GM, Brouillette RT. Sleep. 8: Paediatric obstructive sleep apnoea. Thorax 2005;60(6):511-6. x-wiley/crsRef/2922586
39. Praud JP, Dorion D. Obstructive sleep disordered breathing in children: beyond adenotonsillectomy. Pediatric Pulmonology 2008;43(9):837-43. x-wiley/crsRef/2922588
40. Sakarya EU, Bayar Muluk N, Sakalar EG, Senturk M, Aricigil M, Bafaqeeh SA, et al. Use of intranasal corticosteroids in adenotonsillar hypertrophy. Journal of Laryngology and Otology 2017;131(5):384-90. x-wiley/crsRef/12649916
41. Shen L, Lin Z, Xu Y, Yang Z. [Discussion on the treatment methods of pediatric obstructive sleep apnea hypopnea syndrome]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke za Zhi [Chinese Journal of Otorhinolaryngology Head and Neck Surgery] 2014;49(7):574-81. x-wiley/crsRef/12649918
42. Sterni LM, Tunkel DE. Obstructive sleep apnea in children: an update. Pediatric Clinics of North America 2003;50(2):427-43. x-wiley/crsRef/2922590
43. Sujanska A, Durdik P, Rabasco J, Vitelli O, Pietropaoli N, Villa MP. Surgical and non-surgical therapy of obstructive sleep apnea syndrome in children. Acta Medica (Hradec Kralove) / Universitas Carolina, Facultas Medica Hradec Kralove 2014;57(4):135-141. x-wiley/crsRef/12649920
44. Tapia IE, Marcus CL. Newer treatment modalities for pediatric obstructive sleep apnea. Paediatric Respiratory Reviews 2013;14(3):199-203. x-wiley/crsRef/12649922
45. Traeger N, Prashad PS. Repeated polysomnograms after antiinflammatory therapy of mild pediatric OSA. Chest 2014;146(6):e226. x-wiley/crsRef/12649924
46. Varricchio A, Tortoriello G, Capasso M, De Lucia A, Marchisio P, Varricchio AM, et al. Prevention of surgery in children with adenoidal hypertrophy treated with intranasal flunisolide: a 12-month follow-up. Journal of Biological Regulators and Homeostatic Agents 2009;23(2):95-101. x-wiley/crsRef/2922592
47. Verse T, Pirsig W, Stuck BA, Hörmann K, Maurer JT. Recent developments in the treatment of obstructive sleep apnea. American Journal of Respiratory Medicine 2003;2(2):157-68. x-wiley/crsRef/2922594
48. Wang B, Liang J. The effect of montelukast on mild persistent OSA after adenotonsillectomy in children: a preliminary study. Otolaryngology ‒ Head and Neck Surgery 2017;156(5):952-4. x-wiley/crsRef/12649926
49. Wheeler AJ, Van Someren V. Fluticasone for obstructive sleep apnea. Journal of Pediatrics 2002;140(4):489. x-wiley/crsRef/2922596
50. Whitla L, Lennon P. Non-surgical management of obstructive sleep apnea: a review. Paediatrics & International Child Health 2016;37(1):1-5. x-wiley/crsRef/12649928
51. Yang DZ, Liang J, Zhang F, Yao HB, Shu Y. Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children. Medicine (Baltimore) 2017;96(19):e6628. x-wiley/crsRef/12649930
52. Yu C, Cai X, Wen Z, Liang D, Hu Q, Ni L, Lin J. [A comparative study on efficiency of different therapeutics methods used for obstructive sleep apnea hypopnea syndrome in children]. Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics 2015;53(3):172-7. x-wiley/crsRef/12649932
53. Zhang L, Mendoza-Sassi RA, Cesar JA, Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD006286.pub2]x-wiley/crsRef/2922598
54. Zhang J, Chen J, Yin Y, Zhang L, Zhang H. Therapeutic effects of different drugs on obstructive sleep apnea/hypopnea syndrome in children. World Journal of Pediatrics 2017;13:537-543. x-wiley/crsRef/12649934
55. Zhou LC, Zhu YY, Ding XX, Yang XF, Wang CG. Study on treatment of child snore syndrome with combination of Chinese traditional and western medicine. Chinese Journal of Clinical Rehabilitation 2002;6:2980. x-wiley/crsRef/2922600
56. NCT00912171. Efficacy of oral leukotriene in long term therapy of mild and moderate obstructive sleep apnea syndrome in children (SB-OSAS). clinicaltrials.gov/ct2/show/NCT00912171 (first received 3 June 2009). x-wiley/crsRef/12649936
57. ChiCTR-TRC-09000700. Nasal Corticosteroids as Treatment for Childhood Obstructive Sleep Apnoea. Trial Registration ChiCTR:http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-09000700 (Accessed November 2019). x-wiley/crsRef/12649938
58. ChiCTR-TRC-12002963. The efficacy of intranasal budesonide and leukotriene modifier therapy for mild- moderate pediatric obstructive sleep apnea hypopnea syndrome. www.chictr.org.cn/hvshowproject.aspx?id=4955 (first received 15 November 2012). x-wiley/crsRef/12649940
59. NCT02180672. Steroids for Pediatric Apnea Research in Kids (SPARK). clinicaltrials.gov/ct2/show/NCT02180672 (first received 14 September 2014). x-wiley/crsRef/12649942
60. Subcommittee on Obstructive Sleep Apnea Syndrome, American Academy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109(4):704-12.
61. Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al. American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012;130(3):576-84.
62. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Westchester, Illinois: American Academy of Sleep Medicine, 2006.
63. Alexopoulos EI, Kaditis AG, Kalampouka E, Kostadima E, Angelopoulos NV, Mikraki V, at al. Nasal corticosteroids for children with snoring. Pediatric Pulmonology 2004;38(2):161-7.
64. Alsubie HS, BaHammam AS. Obstructive sleep apnoea: children are not little adults. Paediatric Respiratory Reviews 2017;21:72-9.
65. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, et al. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine 2012;8(5):597-619.
66. Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, Mitchell RB, Promchiarak J, Simakajornboon N, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. American Journal of Respiratory and Critical Care Medicine 2010;182(5):676-83.
67. Brockmann PE, Bertrand P, Castro-Rodriguez JA. Influence of asthma on sleep disordered breathing in children: a systematic review. Sleep Medicine Reviews 2014;18(5):393-7.
68. Cochrane Airways Trials Register. airways.cochrane.org/trials-register (accessed 8 April 2019).
69. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edition. Hillsdale, NJ: Lawrence Earlbaum Associates, 1988.
70. Crysdale WS, Russel D. Complications of tonsillectomy and adenoidectomy in 9409 children observed overnight. CMAJ: Canadian Medical Association Journal 1986;135(10):1139-42.
71. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
72. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. American Journal of Respiratory and Critical Care Medicine 2005;172(3):364-70.
73. McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), accessed prior to 24 December 2019.
74. Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
75. Iber C, Ancoli-Israel S, Chesson A, Quan SF, American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Event: Rules, Terminology and Technical Specifications. 1st Edition. Westchester, IL: American Academy of Sleep Medicine, 2007.
76. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics 2006;117(1):e61-6.
77. NCT00599534. Controlled trial on effect of montelukast treatment in children with obstructive sleep apnea syndrome. clinicaltrials.gov/ct2/show/NCT00599534 (first received 23 January 2008).
78. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnea in patients with co-existing rhinitis. Thorax 2004;59(1):50-5.
79. Lee WC, Sharp JF. Complications of paediatric tonsillectomy post-discharge. Journal of Laryngology and Otology 1996;110(2):136-40.
80. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proceedings of the American Thoracic Society 2008;5(2):242-52.
81. Marcus CL. Sleep-disordered breathing in children. American Journal of Respiratory and Critical Care Medicine 2001;164(1):16-30.
82. Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, et al. Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. New England Journal of Medicine 2013;368(25):2366-76.
83. Mason M, Welsh EJ, Smith I. Drug therapy for obstructive sleep apnea in adults. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD003002.pub3]
84. McColley SA, April MM, Carroll JL, Naclerio RM, Loughlin GM. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Archives of Otolaryngology ‒ Head and Neck Surgery 1992;118(9):940-3.
85. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997;111(1):170-3.
86. Higgins J, Lasserson T, Chandler J, Tovey D, Churchill R. Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates (version 1.07). community.cochrane.org/mecir-manual (accessed 29 April 2019).
87. Rosen CL, Larkin EK, Kirchner HL, Emancipator JL, Bivins SF, Surovec SA, et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. Journal of Pediatratrics 2003;142(4):383-9.
88. Ruboyianes JM, Cruz RM. Pediatric adenotonsillectomy for obstructive sleep apnea. Ear, Nose, & Throat Journal 1996;75(7):430-3.
89. Verhulst SL, Van Gaal L, De Backer W, Desager K. The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents. Sleep Medicine Reviews 2008;12(5):339-46.
90. Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive sleep apnea in children. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD007074.pub2]